Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt Meeting highlights from ICMRA global regulatory workshop on COVID-19 observational studies and real world data 16 april 2020NewsHumanCOVID-19Research and development Guidance on regulatory requirements in the context of the COVID-19 pandemic 10 april 2020NewsHumanCOVID-19Regulatory and procedural guidanceMedicines Update on EU actions to support availability of medicines during COVID-19 pandemic 10 april 2020Press releaseHumanCorporateCOVID-19Medicines EMA establishes task force to take quick and coordinated regulatory action related to COVID-19 medicines 9 april 2020Press releaseHumanCorporateCOVID-19 Global regulators stress need for robust evidence on COVID-19 treatments 9 april 2020Press releaseHumanCOVID-19Clinical trialsCompassionate useMedicines Global regulators discuss observational studies of real world data for COVID-19 medicines 7 april 2020NewsHumanCOVID-19 Essential work to combat the COVID-19 pandemic to continue during EMA's Easter break from 9 to 13 April 2020 7 april 2020NewsCorporateCOVID-19 EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic 6 april 2020Press releaseHumanMedicine shortagesMedicines EMA provides recommendations on compassionate use of remdesivir for COVID-19 3 april 2020Press releaseHumanCOVID-19Medicines for use outside the EU International regulators discuss available knowledge supporting COVID-19 medicine development 3 april 2020NewsHumanCOVID-19MedicinesResearch and developmentVaccines 1 … 88 89 90 91 92 Page 92 of 383 93 94 95 96 … 383
Meeting highlights from ICMRA global regulatory workshop on COVID-19 observational studies and real world data 16 april 2020NewsHumanCOVID-19Research and development
Guidance on regulatory requirements in the context of the COVID-19 pandemic 10 april 2020NewsHumanCOVID-19Regulatory and procedural guidanceMedicines
Update on EU actions to support availability of medicines during COVID-19 pandemic 10 april 2020Press releaseHumanCorporateCOVID-19Medicines
EMA establishes task force to take quick and coordinated regulatory action related to COVID-19 medicines 9 april 2020Press releaseHumanCorporateCOVID-19
Global regulators stress need for robust evidence on COVID-19 treatments 9 april 2020Press releaseHumanCOVID-19Clinical trialsCompassionate useMedicines
Global regulators discuss observational studies of real world data for COVID-19 medicines 7 april 2020NewsHumanCOVID-19
Essential work to combat the COVID-19 pandemic to continue during EMA's Easter break from 9 to 13 April 2020 7 april 2020NewsCorporateCOVID-19
EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic 6 april 2020Press releaseHumanMedicine shortagesMedicines
EMA provides recommendations on compassionate use of remdesivir for COVID-19 3 april 2020Press releaseHumanCOVID-19Medicines for use outside the EU
International regulators discuss available knowledge supporting COVID-19 medicine development 3 april 2020NewsHumanCOVID-19MedicinesResearch and developmentVaccines